	Diagnostic performance of serum vitamin D metabolites and 14 inorganic elements in early prediction of kidney neoplasm. Front Oncol Dai C, Zhang B, Deng Q, Feng J. PMID: 42558352 [PubMed]
	Tumor fat composition predicts response to everolimus and supports low-dose therapy in TSC-associated renal angiomyolipomas: a multicenter prospective study. Front Oncol Gao K, Duan Y, Ren B, Guo B, Su R, Gu H, Chen F, Zhang C, Wu G, Ni J. PMID: 42558341 [PubMed]
	Artificial intelligence in the early diagnosis of prostate cancer: from multimodal imaging to liquid biopsy. Front Oncol Xie J, Yin Z, Gao R, Qiu Z, Zhou Q. PMID: 42558280 [PubMed]
	Efficacy of Medical Interventions for Erectile Dysfunction after Prostate Cancer Treatment: A Systematic Review and Network Meta-Analysis. World J Mens Health Eshetie S, Ejekpokpo O, Charlick M, Tiruye T, Jay A, Higgs B, Shepherd A, Beckmann K. PMID: 42557727 [PubMed - as supplied by publisher]
	Bibliometric analysis of renal function preservation in robot-assisted partial nephrectomy: research trends, functional outcomes, and CKD-related perspectives. J Robot Surg Niu H, Xu C, Huang L, Tian Z, Man J, Yang L, Wang J. PMID: 42557524 [PubMed - indexed for MEDLINE]
	Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group. Nat Rev Urol Hensley PJ, Teoh JYC, Li R, Gupta S, Bukavina L, Mouw KW, Lobo N, Maiorano BA, Tan WS, Agarwal P, Al-Ahmadie HA, Bivalacqua TJ, Cheng L, Flaig TW, Guo CC, Horowitz A, Kassouf W, Kates MR, Konety BR, Kukreja JB, Lotan Y, McConkey DJ, Mertens LS, Mir MC, Moschini M, Necchi A, Oualla K, Packiam VT, Schmidt B, Buckley RJ, Kamat AM. PMID: 42557383 [PubMed - as supplied by publisher]
	Benign but burdensome: Complications and management of benign prostatic hyperplasia during active surveillance of prostate cancer in a large cohort. Urol Oncol Monaco A, Koh S, Guo A, Garcia RS, Ellis T, Palasi S, Lawen T, da Silva RD, Gregg JR. PMID: 42557189 [PubMed - as supplied by publisher]
	Lutetium-177-PSMA-617 in Oligo-metastatic Hormone-sensitive Prostate Cancer (BULLSEYE): A Trial Update. Eur Urol Focus Privé BM, Oprea-Lager DE, Muselaers CHJ, Timmermans B, van Oort IM, Mehra N, Michiel Sedelaar JP, Vrachimis A, Noordzij W, Nagarajah J. PMID: 42557180 [PubMed - as supplied by publisher]
	Bacillus Calmette-GuÃ©rin (BCG) with or without Immune Checkpoint Blockade in BCG-NaÃ¯ve High-Risk Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-Analysis. Crit Rev Oncol Hematol Saâd MA, Antari A, Taleb I, El Omri S, Traoré H, Chahbounia I, Sella I, Poudiougou A, Sano FD, Omri L, Elm'hadi C, Lamine S, Mokhlis MA, Aalaoui L, Debbagh A, Khmamouche MR, Slimani KA, Sbitti Y, Mahfoud T, Errihani H, Tanz R. PMID: 42556596 [PubMed - as supplied by publisher]
	Prognostic clinical indicators in patients with metastatic castration-resistant prostate cancer treated with radium-223 plus enzalutamide: Data from patients in J-RAP-BSI trial. Hell J Nucl Med Kitajima K, Kuyama J, Kawahara T, Suga T, Otani T, Sugawara S, Kono Y, Tamaki Y, Seko-Nitta A, Ishiwata Y, Ito K, Toriihara A, Watanabe S, Hosono M, Yamamoto S, Narita M, Yamakado K. PMID: 42555489 [PubMed - as supplied by publisher]
	"Renal cell carcinoma, not otherwise specified" is not a sufficient diagnostic classification. Virchows Arch Yildirim NA, Bayrak BY, Cheng L, Akgul M. PMID: 42554860 [PubMed - as supplied by publisher]
	MRI Standards for Prostate Cancer Screening in the PRISM Consensus Recommendations. AJR Am J Roentgenol Ponsiglione A, Brembilla G. PMID: 42554687 [PubMed - as supplied by publisher]
	Biopsy Versus Clear-Cell Likelihood Score for Diagnosing Clear Cell Renal Cell Carcinoma in Small Renal Masses on MRI: A Propensity Score-Matched Analysis. AJR Am J Roentgenol Joo Y, Yoon J, Tse JR, Cho SW, Jung DC, Kang BC, Oh YT, Park JH. PMID: 42554684 [PubMed - as supplied by publisher]
	A Platform-Independent Binary Gene-Pair Signature Derived from CRPC-Enriched Single-Cell Transcriptomics for Predicting Recurrence-Free Survival in Prostate Cancer. Cancer Manag Res He Y, Li B, Tan Z, Jiang K, Ju W, Yu W, Zhang M, Liang C. PMID: 42553741 [PubMed]
	Case Report: Diagnosis and treatment report and literature review of 2 cases of VHL-deficient renal cell carcinoma. Front Oncol Wang Y, Gao T, Ren N, Liu Y, Li Q, Guo X. PMID: 42553075 [PubMed]
	Diet and Physical Activity as Mediators of Weight Loss in a Digital Prostate Cancer Survivorship Intervention for Men: Secondary Analysis of the PC-PEP Randomized Trial. Am J Mens Health Power B, Smith NK, Ilie G, Rendon RA, Mason R, Kokorovic A, MacDonald C, Patil N, Bowes D, Bailly G, Wilke D, Langley E, Rutledge R. PMID: 42552876 [PubMed - indexed for MEDLINE]
	Frailty and Social Isolation of Elderly Prostate Cancer Patients: A Chain Mediating and Network Analysis of Illness Perception and Acceptance. Nurs Open Liu Y, Shen C, Huang Y, Jin Y, Zhang X, Wang H, Zhou J, Yao X, Li H, Chen W. PMID: 42552627 [PubMed - indexed for MEDLINE]
	Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval Era. Ann Surg Oncol Filzmayer M, Petix M, Quarta L, Orlandi F, Goyal JA, Carmignani L, Briganti A, Micali S, Shariat SF, Wenzel M, Heß-Busch Y, Humke C, Saad F, Chun FK, Karakiewicz PI. PMID: 42552493 [PubMed - as supplied by publisher]
	PSMA PET in Prostate Cancer: Clinical Value, Access Challenges, and Priorities for Implementation. Eur Urol Oncol Peyrottes A, Turpin L, Hernández LF, Rivas JG, Rouprêt M. PMID: 42552166 [PubMed - as supplied by publisher]
	Re: Emanuele Messina, Antonella Borrelli, Alessandro Sciarra, et al. Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA). Eur Urol 2025;89:246-57. Eur Urol Luca S, Ferrando L, Porpiglia F. PMID: 42552153 [PubMed - as supplied by publisher]

Articles 1 - 20 / 180525

Page 1 of 9027



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy